Hereditary pseudocholinesterase deficiency discovery after electroconvulsive therapy

Area of Science:

• Anesthesiology
• Clinical Biochemistry
• Pharmacology

Background:

• Inherited pseudocholinesterase deficiency is a rare genetic disorder affecting butyrylcholinesterase enzyme activity.
• This enzyme is crucial for metabolizing certain muscle relaxants, like succinylcholine, used in anesthesia and ECT.
• Deficiency can lead to prolonged neuromuscular blockade and extended recovery times post-procedure.

Observation:

• A 25-year-old woman undergoing electroconvulsive therapy (ECT) for depression experienced delayed motor function recovery after succinylcholine administration.
• Standard anesthetic protocols were followed, but the patient exhibited an unusually prolonged response to the neuromuscular blocking agent.
• Post-procedure investigations revealed a severe form of inherited pseudocholinesterase deficiency.

Findings:

• The patient's severe pseudocholinesterase deficiency was confirmed through diagnostic testing.
• This genetic condition explained the delayed hydrolysis of succinylcholine, leading to prolonged paralysis.
• The case demonstrates a direct link between pseudocholinesterase deficiency and adverse anesthetic events in a clinical setting.

Implications:

• Pseudocholinesterase deficiency necessitates careful anesthetic planning, particularly regarding the choice and dosage of muscle relaxants.
• Awareness of this condition is vital for anesthesiologists and clinicians administering ECT to prevent prolonged paralysis.
• Genetic screening or awareness of family history may be beneficial for patients undergoing procedures requiring succinylcholine or similar agents.